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Abstract
Introduction. The hormone-dependent events that occur throughout the first wave of spermatogenesis, such as 
the establishment of the number of Sertoli cells (SCs) and spermatogonial stem cells (SSCs) within the semini-
ferous cords and the setting up of the blood-testis barrier, are important for adult male fertility. Any changes in 
the T/DHT ratio can result in male subfertility or even infertility. In this study we aimed to evaluate effects of 
paternal exposure to 5-alpha reductase type 2 inhibitor, finasteride on litter size, androgen levels and germ cell 
apoptosis in male offspring during postnatal development.
Material and methods. The subjects of the study were 7, 14, 21/22, 28, and 90-day-old Wistar male rats (F1:Fin) 
born from females fertilized by finasteride-treated rats. Offspring born from untreated parental animals were 
used as a control group (F1:Control). Animals and the collected testes were weighed, blood and intratesticular 
levels of T and DHT were measured by ELISA, and the apoptotic index of testicular cells was evaluated by 
TUNEL technique.
Results. We observed difficulties in obtaining male newborns from female rats fertilized by finasteride-treated 
male rats. In the F1:Fin rats, changes in the body and testes weights occurred, and a lower number of apoptotic 
cells was found during postnatal maturation of the seminiferous epithelium. Changes in androgen concentrations 
during the first spermatogenesis wave and adult life were also evident. 
Conclusion. Finasteride treatment of male adult rats may not only cause a decrease in the fertility of parental 
rats, but also could lead to incorrect, androgen-sensitive course of spermatogenesis in their offspring. (Folia 
Histochemica et Cytobiologica 2015, Vol. 53, No. 3, 236–248)
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Introduction
During the first week of postnatal life, the primitive 
seminiferous cords contain gonocytes (precursors of 
spermatogonial stem cells, SCCs), SSCs, and sup-
portive Sertoli cells (SCs) [1]. Between the first and 
sixth week, the first wave of spermatogenesis takes 
place in the rat gonad [1, 2]. Throughout this period, 
spermatozoa production is limited because of massive 
cell apoptosis [3], and in this way the proper number 
of SSCs and SCs [4, 5] for sperm production in adult 
gonads is established [6]. Moreover, at about the 15th 
to 18th postnatal day, the physiological blood-testis 
barrier is created, the lumen of the seminiferous cords 
open, and the Sertoli cells undertake their secretory 
function [6, 7]. 
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The morphology and function of the testis is 
under the control of hypothalamic–pituitary–gonad 
axis and locally produced steroid hormones such as 
testosterone (T) and dihydrotestosterone (DHT), 
which is much more biologically active than T [8]. 
The irreversible reduction of T into DHT is carried 
out by 5a-reductase [9]. The most common isoform 
in the male reproductive system is 5a-reductase type 
2 (5a-red2) [10]. Finasteride is a steroidal inhibitor of 
5a-red2 [11] that blocks the conversion of T into DHT 
and is often used for the treatment of prostate can-
cer or benign prostatic hyperplasia (BPH) at a dose 
5 mg/day. Moreover, dermatologists frequently use 
1 mg finasteride daily in the chronic therapy of pre-
maturely balding young men (AGA; androgenetic 
alopecia) [12]. It has been postulated that long-term 
finasteride therapy, often lasting for many years, has 
no negative influence on androgen-dependent pro-
cesses such as fertility or libido [13, 14]. However, 
many studies have documented contrary findings [15, 
16]. In patients administered finasteride, a decrease 
in semen parameters [17–19], difficulties in fertiliza-
tion [18], sexual dysfunction such as low libido, and 
problems with erection and orgasm are observed [20]. 
Some of these symptoms persist for many months af-
ter administration of the drug has ceased [20]. In spite 
of these persistent sexual side effects, patients also 
suffer from melancholy, depressive syndromes, and 
suicidal thoughts [21]. Other case reports reveal that 
low-dose finasteride results in sperm DNA damage 
(elevated sperm DNA fragmentation index) [22, 23]. 
Transmission electron microscopy studies revealed 
altered sperm morphology consistent with necrosis, 
and FISH data showed elevated frequencies of diploi-
dy and sex chromosome disomy [24]. One year after 
the cessation of finasteride treatment, the meiotic 
pattern had not changed and elevated diploidy and sex 
chromosome disomy were still present; however, the 
motility and sperm morphology had improved [24]. 
Furthermore, it has been suggested that there is still 
no documented full-term pregnancy or live birth from 
couples in which the man received finasteride [22]. 
In rat, finasteride treatment decreased fertility 
connected with the affected function of the acces-
sory glands [25] and promoted partial inhibition of 
spermatogenesis [26]. In studies of castrated male 
rats, 5a-reductase inhibitors were found to have 
a detrimental effect on erectile function, which was 
restored with DHT [27, 28]. 
Nowadays, a great deal of interest has been fo-
cused on endocrine disruptors (EDs) that mimic or 
block sex hormones, disrupt homeostasis and hence 
can negatively influence reproductive system develop-
ment and function [29, 30]. Finasteride, as a drug 
that modulates activity of the key enzyme involved 
in metabolism of testosterone, can fit the definition 
of endocrine disruptor. 
Taking together the fact that finasteride treatment 
can result in persistent sexual side effects and change 
androgens concentration similarly to endocrine 
disruptors, the aim of this preliminary study was 
to analyze the T and DHT levels and their possible 
correlation with germ cell apoptosis during testes 
postnatal maturation of progeny of paternal rats 
treated by finasteride. 
Material and methods
Animals. The study was conducted on albino Wistar rats. 
Parental generation (F0) was used to obtain the next male 
generation (F1). The experiment was conducted in full ac-
cordance with Polish law and with the approval of the Local 
Ethics Committee for Scientific Experiments on Animals in 
Szczecin, Poland. 
Parental generation was represented by 12 female and 
10 male rats (for mating purposes only). At the beginning 
of the experiments, the rats were 12 weeks old. During the 
adaptation period (1 week) the animals were housed in 
cages (3 female or 1 male per cage) in the Animal Facility 
of Pomeranian Medical University. The room humidity was 
approximately 55%, and the air temperature was 22 ± 2°C. 
The lighting, on a 12/12-hour cycle. After the adaptation, the 
males were randomly divided into two groups (F0:Control, 
n = 4; and F0:Fin, n = 6). Females and males from control 
group were not given any medicaments. The six male rats 
from F0:Fin group were given finasteride (Proscar®, MSD, 
Carmlington, UK) 5 mg/kg/bw daily. The finasteride was 
given once per day (in the morning) as a small pellet of 
finasteride powder stuck in bread. The pellet was served to 
each experimental parental male rat. The animals willingly 
ate the pellets from the hand of the person performing 
the experiments. The paternal control group (F0:Control) 
received the same bread pellet, but without finasteride. 
The dose of finasteride was the same as in our previous 
investigation [31] and as described by others [32, 33]. 
The period of finasteride treatment before mating lasted 
56 days, according to the results of our previous study which 
demonstrated pathomorphological changes in the semi-
niferous epithelium [31]. Male rats received finasteride 
up to the end of the experiment (for 4–5 months). Once 
a week the animals were weighed, and finasteride dose was 
adequately adjusted.
We started mating couples from F0:Control and F0:Fin 
groups at the same time subsequently the age of the parental 
animals was comparable. Each mating pair was kept in one 
cage. After one week, the females were separated from the 
males, and each pregnant female rat was placed in a separate 
cage. Standard food and tap water were freely available.
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Generation of filial animals. The control group (F1:Con-
trol, n = 30) included the male rats born from the females 
fertilized by vehicle-treated male rats. The experimental 
group (F1:Fin, n = 30) were male rats that were born from 
females fertilized by finasteride-treated male rats. The ob-
jective of the experiment was to sample gonads and blood 
from F1 rats in 7, 14, 21, 28 and 90 postnatal day (PND) of 
life. The female pregnant rats also gave birth on weekends 
when sections were not possible, so groups of 22-day-old rats 
(22 PND F1:Control and 22 PND F1:Fin) were included in 
the experiment. Each age group included 5 male rats. Our 
experimental model of gonad maturity is justified by the fact 
that in the seminiferous epithelium of 7-day-old rats, only 
gonocytes, SCs, and SSCs are present. During maturation 
(i.e. successive weeks of the experiment), other generations 
of germ cells occur within SE [1, 2]. A completely mature 
gonad with spermatozoa production ability is found in 
3-month-old rats (90 days old). 
The time of pupils’ collecting period was scheduled for 
4–5 months to avoid aging of the parental generation. Due to 
the problem with obtaining male newborns of F1:Fin groups 
(the low number of pups in the litters, and elimination 
newborns by female rats) the mating of parental rats were 
performed one more time with the new purchased animals 
in the same designed way as described above. 
After thiopental anesthesia (120 mg/kg bw, i.p., Bio-
chemie GmbH, Wien, Austria) the blood and left testes 
(5 animals per each age group of the F1 generation) were 
collected to measure the T and DHT concentration. The 
5 right testes from newborns of each F1 group were used for 
TUNEL assay. Additionally, body and testis weights were 
measured. In each collected litters, the number of newborns 
just after birth was counted. The gender distribution was 
evaluated 1–2 weeks after birth and was checked one more 
time when the prepubertal animals were sacrificed. The 
males that formed 90-day-old group were separated from 
females at one month of age and counted. 
Hormone assays. The frozen testes were taken from li-
quid nitrogen and placed in a thermobox (–21°C). A small 
fragment of the tissue was placed in a metal homogenizer 
(previously cooled in a container with liquid nitrogen) and 
liquid nitrogen was poured over it 2–3 times; it was then 
fragmented with 4–5 hammer blows against a metal mandrel 
(also previously cooled in a container with liquid nitrogen). 
The pulverized and frozen sample (with volume equal to 
that of approximately 1 mg of protein) was then placed with 
a cooled spoon in an Eppendorf tube containing 100 μL phos - 
phate-buffered saline (PBS), according to manufacturer’s 
instruction, previously cooled to 4°C. After brief vortexing, 
homogenization was carried out with a knife homogenizer 
whipper for about 15 s. The extract mixtures were centri-
fuged (3,000 × g for 10 min at 4°C) and the supernatants 
were stored at –80°C until being used for hormone assays.
Blood was obtained from the rat’s heart using EDTA as an 
anticoagulant. The blood was centrifuged for 15 min at 1,000 
× g at 8°C and plasma was collected and stored at –80°C for 
hormone analysis. 
A standard sandwich ELISA assay was performed on tes-
tes’ homogenates and blood plasma using the rat specific DHT 
and T ImmunoAssay System kit (CUSABIO; CBS-E05100r 
and CBS-E07879r), according to the manufacturer’s instruc-
tions. This assay employs the competitive inhibition enzyme 
immunoassay technique. The microtiter plate provided in 
this kit has been pre-coated with goat-anti-rabbit antibody. 
Standards or samples are added to the appropriate microti-
ter plate wells with an antibody specific for DHT or T and 
horseradish peroxidase (HRP) conjugated with DHT or T. 
The competitive inhibition reaction is launched between 
with HRP labeled DHT or T and unlabeled DHT/T with the 
antibody. A substrate solution is added to the wells and the 
color develops in opposite to the amount of DHT or T in the 
sample. The color development is stopped and the intensity 
of the color is measured. The procedure was performed using 
an Asys UVM 340 microplate reader (Asys Hitech GmbH, 
Wien, Austria). The DHT and T protein concentration was 
normalized to total protein levels as measured by a BCA kit 
(Pierce, Life Technologies, Warsaw, Poland), using bovine 
albumin as a standard. The detection range for T was 0.13– 
–25.6 ng/mL with a sensitivity 0.06 ng/mL; for DHT, the de-
tection range was 10–2,000 pg/mL and the sensitivity 5 pg/mL. 
Apoptosis in situ detection. The analysis was carried out 
using a TACS® 2 TdT-DAB In Situ Apoptosis Detection Kit 
(cat. no. 4810-30-K; TRAVIGEN® Inc., Gaithersburg, MD, 
USA). Deparaffinized sections of formalin-fixed testes were 
incubated with proteinase K solution (15 min at RT), rinsed 
in PBS twice, and incubated for 5 minutes with a mixture 
of methanol (POCH, Poland) and 30% hydrogen peroxide 
(Sigma-Aldrich) (45 mL CH3OH + 5 mL H2O2). For the 
next 5 minutes, the slides were covered with TdT Labeling 
Buffer and then incubated with Labeling Reaction Mix (mix-
ture of TdT dNTP Mix, TdT Enzyme, Mn2+, TdT Labeling 
Buffer) for one hour. The negative control was incubated 
with Labeling Reaction Mix omitting TdT Enzyme. Then, 
the reaction was inhibited by TdT Stop Buffer, slides were 
rinsed in PBS and labeled with streptavidin conjugated with 
horseradish peroxidase. The chemicals needed to prepare: 
proteinase K solution, TdT Labeling Buffer, Labeling Re-
action Mix, TdT Stop Buffer and streptavidin conjugated 
with HRP were from TRAVIGEN®. To visualize the effect 
of the reaction (places of DNA split), 3,3’-diaminobenzi-
dine was added. Positive staining was defined under Leica 
DM5000B microscope (Leica, Wetzlar, Germany) as brown 
pigmentation of the cell nucleus. The apoptotic cell count 
was evaluated as the number of TUNEL-positive cells in 
10 seminiferous tubules analyzed in five testis sections from 
each F1:Control and F1:Fin group of rats.
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 Statistical analysis. The results were analyzed using Statisti-
ca 6.1 software (StatSoft, Krakow, Poland). The arithmetical 
means and SDs were calculated for each of the parameters. 
The normal distribution of the results for the individual 
variables was obtained using the Shapiro-Wilk test. As 
most of the distributions deviated from a normal distribu-
tion, nonparametric tests were used for further analyses. 
To assess the differences between the investigated groups, 
the nonparametric Mann-Whitney U-test was used. The 
probability p ≤ 0.05 was considered statistically significant. 
Correlations between the parameters were examined with 
Spearman’s rank correlation coefficient (rs). 
Results
Number of pups per litter 
During the experiment 28 litters (14 in F1:Control, 
n = 133; and 14 in F1:Fin, n = 90) were collected 
(Table 1). The number of pups in the litters of the 
F1:Fin groups was lower than in control group (on 
average 6.4 vs. 9.5 pups per litter, respectively). The 
procreation process in this group had to be repeated 
many times, and three times the pups were eaten by 
the females fertilized by the finasteride-treated male 
rats. We did not notice this behavior in the control 
group. Moreover, in many litters, the female offspring 
of the F1:Fin generation predominated (60%   ), in 
contrast to the F1:Control group (45%   ).
Body and testis weight
The offspring of rats in both the F1:Control and 
the F1:Fin groups showed increasing body weight 
throughout the experiment, over the course of natural 
development. This obvious correlation was corrobo-
rated using Spearman’s R-test (rs = 0.97, rs = 0.95 
respectively and p = 0.0001). The statistically signifi-
cant higher body weight of F1:Fin vs. F1:Control was 
observed in 7, 14, and 90 PND (Table 2). 
Testis weight increased over time in both the 
F1:Control and the F1:Fin groups. A statistically signif-
icant positive correlation between the increase in testis 
weight and animal age was demonstrated by Spear-
man’s R-test (F1:Control rs = 0.96; F1:Fin rs = 0.97; 
p = 0.0001). Additionally, statistically significant 
differences were noticed in testis weight between 
the F1:Control and the F1:Fin groups of rats at 14, 
22, 28, and 90 days after birth. A higher weight was 
characteristic of the testis of the 14 PND, 22 PND, 
and 90 PND rats in the F1:Fin group, while in the 
28 PND rats of the F1:Control group, the testes were 
Table 1. The number of collected newborns born from females fertilized by control and finasteride-administrated male 
rats with detailed number of males and females within each litter
Number  
of the litter
F1:Control
Total
F1:Fin
TotalPups per liter Pups per liter 
Male Female Male Female
1. 8 3 11 3 6 9
2. 4 6 10 3 2 5
3. 6 7 13 1 – 1a
4. 2 – 2 2 2 4b
5. 7 5 12 2 1 3
6. 3 5 8 2 4 6c
7. 6 1 7 4 4 8
8. 6 – 6 3 3 6
9. 4 9 13 3 7 10
10. 5 2 7 1 6 7
11. 10 1 11 2 5 7
12. 4 8 12 1 1 2
13. 6 7 13 5 7 12
14. 3 5 8 4 6 10
Total 74 59 133 36 54 90
F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-treated male rats, respectively. a, b, c — almost all, half 
of all, one third of newborns in litter was eaten by female, respectively
240 Agnieszka Kolasa-Wolosiuk et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0025
www.fhc.viamedica.pl
notably heavier by about 7.9% in comparison to the 
F1:Fin (Table 2). 
Hormone levels
Serum concentration of androgens 
During the first weeks of development, the serum 
androgen levels fluctuated, and in immature rats 
showed much higher values then in the mature ani-
mals (Figures 1 and 2). The statistically significant 
differences in T levels between F1:Fin and F1:Control 
rat groups on the days following postnatal develop-
ment were noticed at 14th PND (2.3 times lower than 
in control), 28th PND (increase by 23%), and 90th PND 
(increase by 98%) (Figure 1).
To compare F1:Fin with the F1:Control rats in the 
following days of the experiment, statistically significant 
differences in DHT levels were found for at 14, 22, and 
90 PND. In F1:Fin group of rats, on the 14th PND serum 
level of DHT was 2 times lower, on the 22nd PND — 
increased by ca. 30%, and on the 90 PND declined by 
1.6 times in comparison to control (Figure 2). 
The statistical analysis showed a significant strong 
negative correlation of the plasma T concentration 
between the early developmental period and the pe-
riod of sexual maturity in the F1:Control (rs = –0.87, 
p = 0.00001) and F1:Fin (rs = –0.52, p = 0.00005) 
groups. Moreover, analysis of Spearman’s rank 
correlation coefficient showed a strong negative 
correlation between plasma DHT concentration 
Table 2. Body and testis weight of rat offspring born from females fertilized by control or finasteride-treated male rats
Body weight [g] Testis weight [mg]
Age F1:Control F1:Fin % of change vs. 
F1:Control
F1:Control F1:Fin % of change vs. 
F1:Control
7 PND 17.45 ± 2.69a  20.23 ± 2.74a ≠16% 16.07 ± 2.86 15.56 ± 2.59 ≠3.2% 
14 PND 28.34 ± 4.63b  43.50 ± 5.64b ≠53.5%  52.53 ± 6.56a    69.71 ± 13.10a ≠32.7%
21 PND 48.25 ± 2.470 46.61 ± 3.99 Ø3.4% 137.32 ± 15.19 139.41 ± 20.87 ≠1.5%
22 PND 45.00 ± 1.400 46.00 ± 2.24 ≠2.2% 129.24 ± 7.74a 142.69 ± 5.29a ≠10.4%
28 PND 63.33 ± 11.93 62.86 ± 4.72 Ø0.7%  265.44 ± 22.11a  244.36 ± 23.89a Ø7.9%
90 PND 295.00 ± 42.42b  371.68 ± 45.09b ≠25.9%  1449.6 ± 13.85a 1732.17 ± 94.41a ≠19.5%
F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-treated male rats, respectively. Values express 
arithmetic means ± SD (n = 5 per each age group). The common superscripts within row denote statistically significant differences between com-
pared groups evaluated by the Mann-Whitney U-test: ap < 0.01, bp < 0.001. The comparisons of F1:Fin vs. F1:Control are expressed as percenta-
ges of decrease (Ø) or increase (≠). PND — postnatal day
Figure 1. Testosterone concentration in blood plasma of control offspring and rats born from females fertilized by  
finasteride-treated male rats. F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finaste - 
ride-treated male rats, respectively. Values are expressed as arithmetic mean, bars represent ± SD; differences were 
evaluated by the Mann-Whitney U-test (n = 5 per each age group). The common letters denote statistically significant 
differences between each compared groups: dp < 0.01, a, b, c, fp < 0.001, e, g, hp < 0.0001. PND — postnatal day
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and the time of development in the F1:Control 
(rs = –0.89, p = 0.00001) and F1:Fin (rs = –0.72, p = 
0.00001) groups of rats; the general differences in the 
evaluated parameters were quite similar to the results 
describing the T levels. 
Concentration of androgens in the testicular tissue 
The highest levels of intratesticular androgens were 
observed in four-week-old rats; the hormone con-
centrations were higher in immature gonads then in 
the mature gonads (Figures 3 and 4). A comparison 
of the F1:Fin and F1:Control groups demonstrated 
a statistically significant reduction in the intratesticu-
lar T on 22nd PND, 28th PND and 90th PND (1.7 times, 
12 times and 9.2 times, respectively) (Figure 3).
Generally, fluctuations in DHT levels were ob-
served both in the control and the finasteride-off-
spring rats (Figure 4). Statistically significant decrease 
in intratesticular DHT levels was observed in F1:Fin 
groups at 21st PND, 22nd PND, and 90th PND (3.3, 3.7 
and 4 times, respectively) compared to the respective 
F1:Control animals.
Figure 2. Dihydrotestosterone concentration in blood plasma of control offspring and rats born from females fertilized 
by finasteride-treated male rats. F1:Control, F1:Fin — rat offspring born from females fertilized by the control or fina-
steride-treated male rats, respectively. Values are expressed as arithmetic mean, bars represent ± SD; differences were 
evaluated by the Mann-Whitney U-test (n = 5 per each age group). The common letters denote statistically significant 
differences between each compared groups: a–gp < 0.001. PND — postnatal day
Figure 3. Testosterone concentration in testis homogenates of control offspring and born from females fertilized by fina-
steride-treated male rats. F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-tre-
ated male rats, respectively. Values are expressed as arithmetic mean, bars represent ± SD; differences were evaluated 
by the Mann-Whitney U-test (n = 5 per each age group). The common letters denote statistically significant differences 
between each compared groups: gp < 0.0001, a–f, h–jp < 0.001. PND — postnatal day.
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Statistical test showed a statistically significant 
strong negative correlation between testicular T 
concentration and developmental time only in F1:Fin 
rats (rs = –0.73, p = 0.00001). The postnatal changes 
in DHT levels correlated negatively with time in the 
F1:Control (rs = –0.52, p = 0.00015) and F1:Fin 
(rs = –0.74, p = 0.00001) groups of rats. 
TUNEL analysis
In seven-day-old rats of both the F1:Control and the 
F1:Fin group, apoptosis was very sporadic (Figure 5A, 
F), on average, there were 0.27–0.28 TUNEL-positive 
cell for each cross-section of seminiferous tubule 
(Table 3). 
Figure 4. Dihydrotestosterone concentration in testis homogenates of control offspring and rats born from females 
fertilized by finasteride-treated male rats. F1:Control, F1:Fin — rat offspring born from females fertilized by the control 
or finasteride-treated male rats, respectively. Values are expressed as arithmetic mean, bars represent ± SD; differences 
were evaluated by the Mann-Whitney U-test (n = 5 per each age group). The common letters denote statistically signifi-
cant differences between each compared groups: a–gp < 0.001. PND — postnatal day
Figure 5. Apoptosis within the testis of rat offspring born from females fertilized by control (A–E) and finasteride-admini-
strated (F–J) male rats detected by TUNEL method. Brown-stained nuclei indicate the apoptosis of germ cells in semi-
niferous epithelium. F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-treated 
male rats, respectively (n = 5 per each age group). Scale bar: 50 μm. PND — postnatal day
A B C D E
F G H I J
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In the following postnatal days of testis develop-
ment (Figure 5B–D, G–I), during the first wave of 
spermatogenesis, apoptosis intensified over time in 
both the groups of rats, though somewhat more (Ta-
ble 3) in the F1:Fin group (Figure 5G–I) than in the 
control rats (Figure 5B–D), up to the third week of 
development; and in F1:Fin, this parameter declined 
in the 28th day of life. The apoptotic cells seemed to be 
large, round primary spermatocytes, probably pachy-
tene spermatocytes. In the gonads of the sexually 
mature (90 PND) F1:Control and F1:Fin rats, only the 
cell nuclei of a few seminiferous tubules manifested 
a positive result in the TUNEL analysis (Figure 5E, J) 
and the scores were similar for both groups, with an 
average of 1.16 and 0.72 cells per tubule (Table 3). 
In both groups of 22-day-old rats, the apoptosis 
process was statistically significantly greater, and was 
found in some whole cross-sections of seminiferous tu-
bules or in single cells in the seminiferous epithelium 
(Figure 6A, B). The statistically significant escalation 
of the apoptotic index was much more noticeable in 
the testis of F1:Control rats (Table 3).
Discussion
Currently, the observed decreasing semen quality 
and increasing male reproductive problems are 
the result of many etiological factors associated 
with lifestyle or exposure to radiation, stimulants, 
environmental agents, and medicines [34–36]. The 
regulation of the development of male reproductive 
system and its correct function is under the control 
of several mechanisms sensitive to both endogenous 
and exogenous factors which begin to operate during 
fetal life [37]. It has been also shown that endocrine 
disruptors have transgenerational effect on male 
Figure 6. Apoptosis within the testis of 22-day-old rat offspring born from females fertilized by control (A) and fina-
steride-administrated (B) male rats detected by the TUNEL method. Black arrows indicate seminiferous tubules with 
single brown-stained nuclei of apoptotic germ cells in the seminiferous epithelium; black asterisks show cross-sections of 
seminiferous tubules with a great number of TUNEL-positive cells. Insert in upper left corner of A — a negative control. 
F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-treated male rats, respecti-
vely (n = 5 per each age group). Scale bar: 200 μm
Table 3. The number of TUNEL-positive cells per cross-section of seminiferous tubule from the testis of the control and 
finasteride offspring rats
Postnatal age 7 PND 14 PND 21 PND 22 PND 28 PND 90 PND
F1:Control 0.27 ± 0.02 0.49 ± 0.09   0.7 ± 0.10 11.6 ± 0.83b 1.02 ± 0.13a 1.16 ± 0.10a
F1:Fin 0.28 ± 0.07 0.52 ± 0.12 0.76 ± 0.14   3.1 ± 0.07b 0.68 ± 0.02a 0.72 ± 0.05a
% of change vs. F1:Control ≠3.7% ≠6.12% ≠8.6% Ø73.3% Ø33.3% Ø37.9%
F1:Control, F1:Fin — rat offspring born from females fertilized by the control or finasteride-treated male rats, respectively. Values are expressed 
as arithmetic means ± SD; differences were evaluated by the Mann–Whitney U-test (n = 5 per each age group). The common superscripts within 
row denote statistically significant differences between compared groups: ap < 0.01, bp < 0.0001. The comparisons of F1:Fin vs. F1:Control are 
expressed as percentages of decrease (Ø) or increase (≠). PND — postnatal day
A B
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fertility [38–40]. In utero dose-dependent exposure 
to finasteride induced permanent effects on andro-
gen-sensitive end points such as anogenital distance, 
nipple retention and malformations of male rat 
and rhesus monkey reproductive tract (absence of 
prostate lobes, ectopic testes, small scrotum, small 
penis, hypospadias) [41, 42]. In addition, finasteride 
is still considerate as a drug, with the possibility of its 
teratogenic effects on semen quality that was tested 
experimentally in a primate model [41]. Prahalada et 
al. administrated to monkeys throughout pregnancy 
daily doses of finasteride, within and above range of 
semen levels of the drug, and effects on the offspring 
were assessed. In that study no abnormalities were 
observed in the offspring, even at doses 60–750 times 
higher than levels found in the semen of men treated 
with recommended dose of finasteride, suggesting 
a large safety margin for potential human exposures 
[41]. However, results of some other reports suggest 
that finasteride could be recognized as a medicine 
that produces persistent sexual side effects [16–20] 
with a negative impact on human fertility [43–45]. 
Thus, finasteride that inhibits reduction of T to DHT 
and hence changes the androgen ratio, could also be 
considered as one of reprotoxicants. 
Caution has been also advised regarding the use 
of finasteride by male members of couples who plan 
to have children [44]. Finasteride-induced secondary 
infertility is speculated to be correlated with higher 
sperm DNA fragmentation indices [22, 23], 1818XY 
diploidy, and 19XY disomy [24]. Approximately 95% 
of the length of the human Y chromosome is taken up 
by a nonrecombining region (NRY) that contains the 
majority (50–60%) of the encoding genes inherited 
from father to son. Some of these genes are crucial for 
fertility: these include AZF1 (azoospermia factor 1), 
BPY2 (basic protein on the Y chromosome), DAZ1 
(deleted in azoospermia), TSPY (testis specific pro-
tein), UTY (ubiquitously transcribed TPR gene on 
the Y chromosome), SRY (sex-determining region); 
Y chromosome also contains so-called male-specific 
regions associated with increased risk of cardiovascu-
lar disease or testis and prostate cancer [46–48]. Most 
of data associated with animals male reproductive 
traits came from studies on mouse, less from studies 
on rat or cattle [49–51]. Also in animals, some of 
Y-chromosomal genes are needed for proliferation of 
spermatogonial stem cell and normal sperm morpho-
logy [49], some of them could be functional in rat and 
non-functional in mouse [50] or are highly conserved 
in some mammalian species [52].
Although in our study, we did not perform any 
analysis of the spermatozoa genome, the difficulties 
in obtaining pups from female rats fertilized by fina-
steride-treated male rats could be associated with 
molecular abnormalities in the sperm, as shown in 
other studies [22–24]. Firstly, we observed the low 
number of pups in the litters. We thus needed to 
repeat the procreation process many times. This fact 
could be associated with weak semen quality (probably 
a side-effect of finasteride). We also observed the elimi-
nation of newborns by female rats. The phenomenon 
of infanticide exists in the animal world: mothers tend 
to kill deformed, sick or weak young pups, only allowing 
healthy ones to survive [53]. Moreover, female pups 
predominated in many litters in our experiment. As was 
mentioned above, even a low dose of finasteride might 
exert a negative effect on sperm DNA integrity [22–24]; 
thus, the unequal distribution of sexes in the litters may 
have been caused by some genetic changes in the sper-
matozoa chromosomes of the finasteride-treated rats. 
Possibly, finasteride like endocrine disruptors could 
induce transgenerational effect. The experimental 
treatment of male mice by dioxin (TCDD) produced 
the alternation in the sex ratio of filial generation [54], 
and exposure of young men to dioxins accumulated in 
the environment increased probability of female births 
[55]. Additionally, the changed gender distribution 
strongly correlated with paternal not maternal dioxin 
exposition [56]. Moreover, Anway et al. showed that 
the in utero exposure of rat fetuses to vincozolin (an-
ti-androgenic endocrine disruptor) resulted in decrease 
of male pups’ number per litter of subsequent F1–F4 
rats’ generation [39] similarly in our F1:Fin genera-
tion. Additionally, our results suggest that finasteride 
treatment could increase the mortality of pups in the 
F1:Fin generation in contrast to Anway et al. [39] study. 
Therefore, according to study by Trasler and Doerksen 
[57] it should be more often emphasized that not only 
maternal but also paternal exposure to harmful chemi-
cals may entail the developmental changes in offspring. 
The surviving F1:Fin offspring developed well, 
and had slightly different body and testis weights 
to the F1:Control animals of the same age. During 
the first 14 postnatal days, F1:Fin rats were signifi-
cantly heavier. Also adult, 90-day-old rats from the 
F1:Fin group were heavier then control rats. These 
observations can be associated with the modulation 
of adipose tissue metabolism by androgens [58], and 
therefore could be affected by changes in T/DHT ratio 
observed in our experiment. Interestingly, also testis 
weight of the 14, 22, and 90-day-old F1:Fin rats were 
statistically heavier than that of the similarly aged rats 
in the F1:Control group, proportionally to the higher 
body mass of these animals. 
Apoptosis is a normal physiological process that 
occurs within testes [5, 59], and the first round of 
spermatogenesis exhibits massive apoptosis of germ 
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cells [3, 6, 59]. In rodents such as golden hamster, 
apoptosis starts on the 14th fetal day, two days prior to 
birth [60]. In rat testis frequency of apoptosis increase 
during the prepubertal period (the first 3–4 weeks) 
of life [7], and this phenomenon was also observed in 
our study: apoptosis sporadically occurred in testes of 
7-day-old rats, and intensified over time during the 
first wave of spermatogenesis in both the F1:Control 
and F1:Fin rats. Similarly to other authors [3], dur-
ing the first wave of spermatogenesis we observed 
numerous apoptotic cells including spermatogonia 
and spermatocytes (mainly pachytene spermatocytes). 
Probably, apoptosis in the seminiferous epithelium is 
required for the normal course of spermatogenesis in 
adult animals [4, 5, 59] to maintain the critical ratio 
of cell numbers between Sertoli and germ cells. Dur-
ing the first wave of spermatogenesis, a short phase 
(culminating in the third or fourth week of life in rat) 
of highly increased apoptosis takes place involving 
mainly spermatocytes [3]. However, the absence of 
apoptosis in 22 PND F1:Fin group in contrast to 
intensification of this process in 22 PND F1:Control 
could have a negative impact on the spermatogo- 
 nium-to-spermatocyte ratio. The altered level of germ 
cell apoptosis within testis of the F1:Fin rats in com-
parison to the control animals observed in our study 
confirms previous studies on influence of anti-an-
drogenic endocrine disruptors on male reproductive 
system [39, 40]. The administration of vincozolin (an 
androgen receptor antagonist) to pregnant rats dur-
ing the embryonic sex determination (embryonic day 
8–14 it the rat) reduced the spermatogenic capacity 
by decreasing germ cell survival in the subsequent F1 
adult male offspring [40] or even resulted in trans-
generational phenotype in subsequent male offspring 
from F1 to F4 generation [38, 39].
Our study confirmed the results of previous studies 
which showed age-dependent significant alterations 
of androgens concentration. It is well known that the 
hormonal activity of testis changes during animal’s life, 
and plasma testosterone concentration in pubertal rats 
is higher than in adult ones [61–63]. The age-depend-
ent alterations of androgen levels are related to the 
type, number and activity of Leydig cells [64–67]. The 
immature and mature adult-type Leydig cells produce 
testosterone 4 and 30 times more testosterone, respec-
tively, that the progenitor Leydig cells [65] which are 
mainly responsible for 5a-reduced androgens release 
[64, 65]. The differences in androgen levels between 
the F1:Fin and F1:Control groups of rats could be re-
lated to results of studies which explored the prenatal 
exposures to anti-androgenic endocrine disruptor like 
flutamide [68] or vinclozolin [40] that reduced serum 
testosterone concentration in adult animals. More-
over, decreased T and DHT levels in F1:Fin rats as 
compared to F1:Control group in 22nd postnatal day 
could be linked with the different apoptosis index in 
seminiferous epithelium of these animals. In general, 
gonadotropins and androgens are known as testicular 
cell survival factors [69]. Exposure of animals to ethane 
1,2-dimetanesualfonate (EDS), a Leydig cell toxicant, 
results in testosterone-depended germ cell apoptosis 
[70–72]. It has to be noted that various mechanism 
of testicular cells apoptosis has been observed. For 
instance, the Leydig cell death does not involve Fas, in 
opposite to apoptosis of germ cell [72] that expressed 
Fas acting with its ligand (FasL) on Sertoli cells [73]. 
The testosterone supplementation of EDS-treated rats 
may play an important role in germ cell survival via sup-
pression of Fas [72]. On opposite site, the fetal exposure 
of male rats to bisphenol A (BPA) that interferences 
with endogenous estrogens did not reduce testosterone 
levels but led to decrease of testis weight and presence 
of immature cells of spermatic lineage within the lumen 
of seminiferous tubules [37]. Another report showed 
that DHT acts as an apoptotic signaling modulator in 
immature rat Sertoli cells: treatment DHT resulted in 
down-regulation of p53, Bax, caspase 9 and 3 mRNAs 
[74]. The progression or regression of cell death is 
very important for proper tissue physiology. It was 
documented that apoptosis blockade could result in 
the atrophy of the seminiferous epithelium and finally 
lead to infertility [75]. Taken together, the mechanism 
of testicular cells apoptosis may be dependent on the 
type of the cell, the type of the androgen or the type 
of the endocrine disruptor.
The diverse changes in blood and intratesticular 
androgen levels (increase and decrease, respectively) 
during postnatal development of the F1:Fin rats in 
comparison to F1:Control animals could be also re-
lated to androgen-binding protein (ABP). In the con-
ventional meaning, ABP increases the concentration 
of androgens in the seminiferous tubule to promote 
spermatogenesis. The in vitro and in vivo experiments 
demonstrate that testosterone increased the ABP 
mRNA and protein in Sertoli cells and promoted 
the secretion of ABP; and removal of testosterone 
from culturing medium induced autophagy of ABP 
by Sertoli cells [76]. In the light of this report, it could 
be possible that the fall of intratesticular androgen 
levels in the F1:Fin groups, that was initiated in 3–4 
week of postnatal life and it has been intensified in 
mature testis could have resulted in the excess of 
free, ABP-unbound androgens that could have been 
released directly into circulation. However, this hy-
pothesis needs to be confirmed experimentally. 
In summary, (i) the difficulties in obtaining 
male offspring from female rats fertilized by fina - 
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steride-treated male rats, (ii) the changes in hormonal 
profiles, and (iii) the changes in TUNEL-positive 
testicular cell numbers allow us to conclude that fi-
nasteride treatment of male adult rats may not only 
cause a decrease in the fertility of parental rats, but 
also could lead to incorrect, androgen-sensitive course 
of spermatogenesis in their offspring.
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